- \n
- \n
Record 2025 performance was driven by proactive inventory positioning and rapid supply chain pivoting following significant global tariff volatility in April.<\/p>\n<\/li>\n
- \n
Management mitigated high Chinese tariffs by shifting production to new facilities in Vietnam, Thailand, and Malaysia while increasing output in India and Egypt.<\/p>\n<\/li>\n
- \n
The first aid segment benefited from the introduction of a patented automatic replenishment system that reduces customer costs by 30% to 50% compared to traditional delivery models.<\/p>\n<\/li>\n
- \n
Operational efficiency was enhanced through robotics investments at three U.S. sites for first aid refill assembly and the deployment of inventory-reconciling drones in North Carolina.<\/p>\n<\/li>\n
- \n
Market share gains in the Westcott cutting tool line were achieved by leveraging patented non-stick and ceramic technologies to differentiate products in the craft and industrial sectors.<\/p>\n<\/li>\n
- \n
The company is transitioning its Med-Nap facility to become a domestic supplier for the broader U.S. medical market by building a microbiology lab and expanding quality assurance teams.<\/p>\n<\/li>\n
- \n
U.S. school and office product sales faced headwinds due to retail customers canceling or delaying orders amidst tariff-related pricing uncertainty.<\/p>\n<\/li>\n<\/ul>\n
- \n
- \n
Management anticipates a return to normalized retail merchandising and promotion cycles in 2026 as the market stabilizes following 2025’s tariff disruptions.<\/p>\n<\/li>\n
- \n
The Q1 2026 move into a new 78,000 square foot Tennessee facility is expected to scale production of Spill Magic and bodily fluid cleanup kits.<\/p>\n<\/li>\n
- \n
The acquisition of My Medic provides a high-growth direct-to-consumer platform with over 500,000 social media followers to be leveraged across the broader first aid portfolio.<\/p>\n<\/li>\n
- \n
Future M&A strategy will prioritize opportunistic horizontal expansion in pre-hospital emergency care and vertical acquisitions of medical component suppliers.<\/p>\n<\/li>\n
- \n
Strategic investments in automated processing equipment and domestic production are positioned to drive margin stability and capture share in the U.S. medical market.<\/p>\n<\/li>\n<\/ul>\n
- \n
- \n
Acquired My Medic in January 2026 for $18.7 million, representing a strategic entry into the advanced first aid and bleed control direct-to-consumer market.<\/p>\n<\/li>\n
- \n
Invested approximately $6 million in a new production facility in Mt. Pleasant, Tennessee, to expand the Spill Magic product line.<\/p>\n<\/li>\n
- \n
Net debt was reduced to $18.5 million by year-end 2025, supported by $13 million in free cash flow generated prior to the Tennessee facility purchase.<\/p>\n<\/li>\n
- \n
Acquired a German direct-to-consumer cutting tool supplier in October 2025 for $1.6 million to bolster European market share despite a weak regional economy.<\/p>\n<\/li>\n<\/ul><\/div>\n
- \n
- \n